Carolinas Wealth Consulting’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-39
| Closed | -$848 | – | 55 |
|
|
2025
Q1 | $848 | Hold |
39
| – | – | ﹤0.01% | 923 |
|
|
2024
Q4 | $1.24K | Hold |
39
| – | – | ﹤0.01% | 910 |
|
|
2024
Q3 | $1.12K | Hold |
39
| – | – | ﹤0.01% | 907 |
|
|
2024
Q2 | $1.49K | Hold |
39
| – | – | ﹤0.01% | 848 |
|
|
2024
Q1 | $2.28K | Sell |
39
-14
| -26% | -$818 | ﹤0.01% | 776 |
|
|
2023
Q4 | $3.15K | Buy |
53
+14
| +36% | +$832 | ﹤0.01% | 689 |
|
|
2023
Q3 | $1.89K | Hold |
39
| – | – | ﹤0.01% | 755 |
|
|
2023
Q2 | $3.53K | Hold |
39
| – | – | ﹤0.01% | 734 |
|
|
2023
Q1 | $2.56K | Buy |
+39
| New | +$2.56K | ﹤0.01% | 783 |
|